onCGnostics: Oncgnostics Receives Seven Digit Euro Investment From Grande Bio-tech Co.

Oncgnostics, a Jena, Germany-based diagnostic company, received a seven digit euro investment from Grande Bio-tech Co. The company intends to use the funds to expand the distribution of its tests developed in the ASEAN countries. Led by Dr. Martina Schmitz, CEO and Scientific Director, Oncgnostics has developed Gyntect for the detection of cervical cancer. Gyntect [...]The post Oncgnostics Receives Seven Digit Euro Investment From Grande Bio-tech Co. appeared first on FinSMEs.